# Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Intravenous Nafithromycin

> **NCT03981887** · PHASE1 · COMPLETED · sponsor: **Wockhardt** · enrollment: 10 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Nafithromycin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03981887
- **Lead sponsor:** Wockhardt
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-18
- **Primary completion:** 2019-07-02
- **Final completion:** 2019-08-07
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2019-10-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03981887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03981887, "Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Intravenous Nafithromycin". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03981887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*